CS logo
small CS logo
McLaren Cancer Institute-Lapeer Region

Lapeer, Michigan, United States
Cancer treatment center in Lapeer, Michigan
1295 Barry Dr Suite B, Lapeer, MI 48446

About McLaren Cancer Institute-Lapeer Region


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
21
NRG Oncology
12
SWOG Cancer Research Network
8
Alliance for Clinical Trials in Oncology
6
ECOG-ACRIN Cancer Research Group
5
GOG Foundation
1
NSABP Foundation Inc
1
RTOG Foundation, Inc.
1
Radiation Therapy Oncology Group
1
Total Rows: 9

Clinical Trials at McLaren Cancer Institute-Lapeer Region


During the past decade, McLaren Cancer Institute-Lapeer Region conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 11 clinical trials were completed. i.e. 550% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44557777131322000011112244Started TrialsCompleted Trails201520162017201820192020051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
2010-09-15
2017-12-16
Terminated
77
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
2011-05-25
Active, not recruiting
1,673
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
S0820, Adenoma and Second Primary Prevention Trial
2013-03-01
2032-02-01
Recruiting
1,340

Rows per page:

1–56 of 56

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "McLaren Cancer Institute-Lapeer Region" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "NRG Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Lapeer Region" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 21National CancerInstitute (NCI): 21NRG Oncology: 12NRG Oncology: 12SWOG Cancer ResearchNetwork: 8SWOG Cancer ResearchNetwork: 8Alliance for ClinicalTrials in Oncology: 6Alliance for ClinicalTrials in Oncology: 6ECOG-ACRIN CancerResearch Group: 5ECOG-ACRIN CancerResearch Group: 5GOG Foundation: 1GOG Foundation: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1RTOG Foundation, Inc.: 1RTOG Foundation, Inc.: 1Radiation TherapyOncology Group: 1Radiation TherapyOncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 34National CancerInstitute (NCI): 34NRG Oncology: 10NRG Oncology: 10Canadian Cancer Trials Group: 5Canadian Cancer Trials Group: 5Radiation TherapyOncology Group: 3Radiation TherapyOncology Group: 3Astellas Pharma Inc: 1Astellas Pharma Inc: 1Bayer: 1Bayer: 1Cancer PreventionPharmaceuticals, Inc.: 1Cancer PreventionPharmaceuticals, Inc.: 1Cancer and LeukemiaGroup B: 1Cancer and LeukemiaGroup B: 1Division of Cancer Control: 1Division of Cancer Control: 1Janssen, LP: 1Janssen, LP: 1

Clinical Trials Conditions at McLaren Cancer Institute-Lapeer Region


According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Lapeer Region" are "Invasive Breast Carcinoma" (4 trials), "Estrogen Receptor Negative" (3 trials), "HER2/Neu Negative" (3 trials), "Progesterone Receptor Negative" (3 trials) and "Stage II Breast Cancer" (3 trials). Many other conditions were trialed in "McLaren Cancer Institute-Lapeer Region" in a lesser frequency.

Clinical Trials Intervention Types at McLaren Cancer Institute-Lapeer Region


Most popular intervention types in "McLaren Cancer Institute-Lapeer Region" are "Drug" (42 trials), "Other" (35 trials), "Radiation" (25 trials), "Biological" (18 trials) and "Procedure" (10 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (20 trials), "Laboratory Biomarker Analysis" (17 trials), "Questionnaire Administration" (12 trials), "Intensity-Modulated Radiation Therapy" (11 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

Clinical Trials Genders at McLaren Cancer Institute-Lapeer Region


The vast majority of trials in "McLaren Cancer Institute-Lapeer Region" are 43 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at McLaren Cancer Institute-Lapeer Region


Currently, there are NaN active trials in "McLaren Cancer Institute-Lapeer Region". undefined are not yet recruiting, 15 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in McLaren Cancer Institute-Lapeer Region, 3 suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in McLaren Cancer Institute-Lapeer Region, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 37Phase 3: 37Phase 2: 23Phase 2: 23Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 32Active, not recruiting: 32Recruiting: 15Recruiting: 15Completed: 3Completed: 3Suspended: 3Suspended: 3Terminated: 3Terminated: 3